臨床泌尿器科72巻1号

2018年01月発行

特集 腎癌に対する薬物療法─最新エビデンスを実臨床に活かす

サイトカイン療法の温故知新

著者： 阿部英行¹ 釜井隆男¹

所属機関： ¹獨協医科大学病院泌尿器科

ページ範囲：P.34 - P.40

文献概要

▶ポイント

・IFNα治療による日本人のOSは，欧米人のOSの約2倍である．

・各リスク分類における，リスク因子の少ない症例を上手く選択すれば，IFNαの効果が期待できる．

・分子標的治療薬や新規免疫治療薬に比較してIFNαは安価で，昨今の医療経済事情にフィットする．

参考文献

1） Interferon-alpha and survival in metastatic renal carcinoma : early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators. Lancet 353 : 14─17, 1999

2） PyrhÖnen S, Salminen E, Ruutu M, et al : Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer. J Clin Oncol 17 : 2859─2867, 1999

3） Caraglia M, Marra M, Pelaia G, et al : Alpha-interferon and its effects on signal transduction pathways. J Cell Physiol 202 : 323─335, 2005

4） González-Navajas JM, Lee J, David M, et al : Immunomodulatory functions of type I interferons. Nat Rev Immunol 12 : 125─135, 2012

5） Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, et al : Direct effects of type I interferons on cells of the immune system. Clin Cancer Res 17 : 2619─2627, 2011

6） Gleave ME, Elhilali M, Fradet Y, et al : Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group. N Engl J Med 338 : 1265─1271, 1998

7） Fyfe G, Fisher RI, Rosenberg SA, et al : Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol 13 : 688─696, 1995

8） Coppin C, Porzsolt F, Awa A, et al : Immunotherapy for advanced renal cell cancer. Cochrane Database of Syst Rev 2005 : CD001425.

9） Akaza H, Kawai K, Tsukamoto T, et al : Successful outcomes using combination therapy of interleukin-2 and interferon-alpha for renal cell carcinoma patients with lung metastasis. Jap J Clin Oncol 40 : 684─689, 2010

10） Motzer RJ, Hutson TE, Tomczak P, et al : Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356 : 115─124, 2007

11） Guidelines on Renal Cell Carcinoma 2017 http://uroweb.org/guideline/renal-cell-carcinoma/

12） NCCN Clinical Practice Guidelines in Oncology “Kidney Cancer” Version 1, 2018 https://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf

13） 日本泌尿器科学会 （編） : 腎癌診療ガイドライン2017年版. メディカルビュー社, 東京, 2017

14） Melichar B, Bracarda S, Matveev V, et al : A multinational phase II trial of bevacizumab with low-dose interferon-alpha2a as first-line treatment of metastatic renal cell carcinoma : BEVLiN. Ann Oncol 24 : 2396─2402, 2013

15） Eto M, Kawano Y, Hirao Y, et al : Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan. BMC Cancer 15 : 667, 2015

16） Tatokoro M, Fujii Y, Kawakami S, et al : Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor （I-CCA therapy） for advanced renal cell carcinoma. Cancer Sci 102 : 137─143, 2011

17） Heng DY, Wells JC, Rini BI, et al : Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma : results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 66 : 704─710, 2014

18） Flanigan RC, Mickisch G, Sylvester R, et al : Cytoreductive nephrectomy in patients with metastatic renal cancer : a combined analysis. J Urology 171 : 1071─1076, 2004

19） Naito S, Yamamoto N, Takayama T, et al : Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era : a cooperative group report of 1463 patients. Eur Urol 57 : 317─325, 2010

20） Shinohara N, Nonomura K, Abe T, et al : A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma. Cancer Sci 103 : 1695─1700, 2012

21） Shinohara N, Obara W, Tatsugami K, et al : Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy. Cancer Sci 106 : 618─626, 2015

22） Unverzagt S, Moldenhauer I, Nothacker M, et al : Immunotherapy for metastatic renal cell carcinoma. Cochrane Database of Syst Rev 2017 ; 5 : CD011673

23） Kawano Y, Takahashi W, Eto M, et al : Prognosis of metastatic renal cell carcinoma with first-line interferon-alpha therapy in the era of molecular-targeted therapy. Cancer Sci 107 : 1013─1017, 2016